Evonik and Ethris have agreed a partnership to develop and [...]

Hongene Biotech Corporation, a contract development and manufacturing organization (CDMO) [...]

Boston-based Strand Therapeutics has raised $153 million in a Series [...]

Hongene has appointed leading lipid nanoparticle (LNP) researcher Pieter Cullis [...]

Collaboration targets faster, lower-cost production of RNA-based therapies with reduced [...]

UK-based biotech N4 Pharma has announced encouraging in vivo results [...]

Selvita has become the first contract research organisation (CRO) to [...]

RNA therapeutics developer Ochre Bio has appointed Dr Elaine Sullivan [...]

Ethris GmbH has been awarded a €10 million grant from [...]

Partnership aims to accelerate development using computational drug design Creyon [...]